Swiss Rockets AG plans to build an innovation center for nuclear medicine within the BIO4 campus

A Memorandum of Understanding was signed in the offices of the Government of Serbia, thus opening up new opportunities for the development of oncology and nuclear medicine. The memorandum was signed by the Minister of Science, Technological Development and Innovation, Jelena Begovic, and the CEO of Swiss Rockets AG, Vladimir Cmiljanovic.

- This company will build a new innovation center for nuclear medicine within the BIO4 campus - Begovic stated on that occasion and added that our people who live and work in Switzerland are the founders of this innovative company, i.e. the Swiss Rockets AG network of companies, with a large number of innovations in their portfolio, and that they have decided to take this step and transfer their knowledge and technologies to Serbia, the Government's official website reports.

The minister added that this company will also aid the development of the startup ecosystem in the field of biotechnology in Serbia and that it has already started cooperation with our scientific and research institutes, such as INEP and the Institute of Chemistry, Technology and Metallurgy (IHTM).

- These institutes are the future tenants of the BIO4 campus, and this is the first concrete project with a Swiss company - she said, expressing his expectation that an increasing number of companies will join it.

Cmiljanovic pointed out that this company decided to enter into cooperation with our country for making the so-called theranostic innovation center.

- These are state-of-the-art hospitals, where we will produce the latest molecules for personalized cancer medicine. We will work with the latest technologies for scanning patients with metastases and then, based on those technologies, we will be able to utilize those molecules in order to successfully treat patients with metastases - Cmiljanovic explained.

He added that this Swiss company transfers crucial technologies to Serbia, and that these technologies will be further developed in our country.

Cmiljanovic pointed out that these projects are very important for patients with tumors, primarily patients with prostate metastases, neuroendocrine tumors, glioblastomas and breast cancer.

Vlada Republike Srbije

Ministarstvo nauke, tehnološkog razvoja i inovacija Republike Srbije

Swiss Rockets doo Beograd

Institut za hemiju, tehnologiju i metalurgiju Beograd

INEP Institut za primenu nuklearne energije Beograd

Government of Serbia

Ministry of Science

Technological Development and Innovation

Swiss Rockets AG

INEP

Institute of Chemistry

Technology and Metallurgy

IHTM

Jelena Begovic

Vladimir Cmiljanovic

BIO4 campus

construction of innovation center for nuclear medicine

development of startup system

theranostics innovation center